Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000246214 | SCV000312083 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000725683 | SCV000338581 | uncertain significance | not provided | 2016-01-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000636573 | SCV000758012 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725683 | SCV001859348 | benign | not provided | 2020-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429188 | SCV002744175 | benign | Inborn genetic diseases | 2020-01-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |